Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack...

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Streptococcus pneumoniae is a significant human pathogen causing diverse infections.
• Pneumococci employ immune evasion strategies, notably against the complement system.
• The bacterial enzyme phosphoglycerate kinase (PGK) interacts with host proteins like plasminogen.

Purpose of the Study:

• To investigate the role of pneumococcal phosphoglycerate kinase (PGK) in modulating the host complement attack.
• To elucidate the mechanism by which PGK interferes with complement-mediated bacterial lysis.

Main Methods:

• Recombinant PGK was used to study interactions with complement components.
• Hemolytic activity assays were performed to assess complement inhibition.
• Binding studies investigated interactions between PGK and membrane attack complex (MAC) proteins (C5, C7, C9).
• Complement deposition assays were conducted on bacterial surfaces.

Main Results:

• PGK directly interacted with MAC components C5, C7, and C9, inhibiting MAC assembly and membrane insertion.
• PGK significantly reduced the hemolytic activity of human serum.
• PGK inhibited C9 polymerization and MAC deposition on the pneumococcal surface via classical and alternative pathways.
• Bound plasmin(ogen) to PGK cleaved C3b, further modifying complement activity.

Conclusions:

• Pneumococcal PGK acts as a novel inhibitor of the terminal complement cascade.
• PGK's interaction with MAC components is a key mechanism for complement evasion by Streptococcus pneumoniae.
• This study reveals a new facet of bacterial pathogenesis and immune system interplay.